A new study at Hebrew University reveals insights into mRNA regulation during embryonic development. The study combines single-cell RNA-Seq and metabolic labeling in zebrafish embryos, distinguishing between newly-transcribed and pre-existing mRNA. This approach quantifies mRNA transcription and degradation rates within individual cell types, uncovering varied regulatory rates across genes and cell-type-specific differences in degradation. Understanding mRNA regulation during embryonic development helps decipher how genes are turned on and off in specific cells at precise times, informing our understanding of development, cell fate decisions, and potential applications in medicine and biology.
A new study led by PhD Student Lior Fishman and team under the guidance of researcher Dr. Michal Rabani from The Alexander Silberman Institute of Life Science at Hebrew University, and in collaboration with researchers from the National Institutes of Health in the USA, sheds light on the intricate process of mRNA regulation during embryonic development, providing novel insights into how pluripotent cells adopt specialized identities through gene expression.
Embryonic development involves pluripotent cells assuming specialized identities by adopting particular gene expression profiles. However, understanding the relative contributions of mRNA transcription and degradation to shaping these profiles has been challenging, particularly within embryos with diverse cellular identities.
In the study, researchers used a technique called single-cell RNA sequencing along with metabolic labelling to track how genes are turned on and off over time in zebrafish embryos. They could tell apart the mRNA that was made new (from the embryo itself) and the mRNA that was already there (from the mother). Using mathematical models, they measured how fast genes were turned on and off in different types of cells as they developed.
The results of the study reveal highly varied regulatory rates across thousands of genes. The researchers observed coordinated transcription and destruction rates for many transcripts and linked differences in degradation to specific sequence elements. Importantly, they identified cell-type-specific differences in degradation, including selective retention of maternal transcripts within primordial germ cells and enveloping layer cells, two of the earliest specified cell types.
Dr. Michal Rabani, senior author of the study, commented, "Our study provides a quantitative approach to studying mRNA regulation during a dynamic spatio-temporal response. This work opens up new avenues for understanding the molecular mechanisms underlying cell fate determination during embryonic development."
The findings of this study contribute to a deeper understanding of mRNA regulation and its role in shaping cellular identities during embryonic development. The research team hopes that their work will pave the way for future studies aimed at unravelling the complexities of gene expression regulation in various biological contexts.
The research paper titled “Cell-type-specific mRNA transcription and degradation kinetics in zebrafish embryogenesis from metabolically labeled single-cell RNA-seq” is now available in Nature and can be accessed at https://doi.org/10.1038/s41467-024-47290-9.
Picture
Credit: Dr. Jeffrey Farrell, NIH
Title: Hybridization chain reaction (HCR) in situs
Title: Experimental Flow
Description – Label injected into the zebrafish embryos at the one-cell stage which is incorporated into zygotic mRNA, while pre-existing maternal mRNA remains unlabeled. Bottom: Depiction of different regulatory strategies - selective stability of maternal mRNA or selective transcription of zygotic mRNA.
Credit – Hebrew University
Researchers:
Lior Fishman1, Avani Modak2, Gal Nechooshtan1, Talya Razin1, Florian Erhard3,4, Aviv Regev5,6, Jeffrey A. Farrell2, Michal Rabani 1
Institutions:
- Department of Genetics, Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Edmond J. Safra Campus
- Division of Developmental Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH
- Institute for Virology and Immunobiology, University of Würzburg
- Chair of Computational Immunology, University of Regensburg
- Department of Biology, MIT
- Klarman Cell Observatory Broad Institute of MIT and Harvard Cambridge
Disclaimer: In these challenging times of war and crisis, Hebrew University of Jerusalem is resolute in its dedication to advancing research and education. We stand in full support of the brave individuals on the frontlines, safeguarding our nation and the well-being of all Israelis, and extend our deepest gratitude and unwavering solidarity to our community and fellow citizens. Together, we shall prevail against the challenges that confront us, and our shared commitment to the well-being of all Israelis and the pursuit of knowledge remains resolute.
The Hebrew University of Jerusalem is Israel's premier academic and research institution. Serving over 23,000 students from 80 countries, the University produces nearly 40% of Israel’s civilian scientific research and has received over 11,000 patents. Faculty and alumni of the Hebrew University have won eight Nobel Prizes and a Fields Medal. For more information about the Hebrew University, please visit http://new.huji.ac.il/en.